AIA Vital Care

AIA Vital Care is a rider, not a standalone policy. It is a critical-illness Asuransi Tambahan that attaches to one of AIA’s unit-linked base products; the cost of insurance is debited from the base policy’s Nilai Akun (investment value). It is structured as a multi-stage CI product covering Minor, Intermediate, Major, Catastrophic, and Diabetes-Complication categories — meaning a single customer can collect multiple partial payouts across the disease progression, not just one terminal lump-sum.

The headline structural features versus a plain-vanilla single-stage CI rider:

1. Three-tier plan ladder (Essential / Enhance / Ultimate) with potential aggregate payout of 150% / 200% / 300% of the Sum Assured across the lifetime of a single insured.
2. Monthly Income Benefit (Ultimate plan only) — pays 1% of SA per month for 100 months on end-stage Cancer, Stroke, or Heart Attack, on top of the lump-sum.
3. Cancer Renewal Benefit (Enhance + Ultimate) — pays the Minor-Cancer SA a second time if cancer is re-diagnosed at least 12 months after the first Minor-Cancer claim.

In one line: A unit-linked-attached, multi-stage CI rider that can pay up to 3x SA across a customer’s lifetime — but only the Ultimate plan unlocks the full structure, and the rider’s cost erodes the base policy’s investment value over time.

---

The brochure illustration uses Ratih Agnesya, 36yo Financial Analyst, 2 children, Ultimate Plan, Rp 1B SA. The decoded payout trajectory:

Critical insight for the agent narrative: the 2.5x headline number is achievable only if (a) the customer holds the Ultimate plan, (b) suffers the right disease sequence (early-stage cancer then second early-stage cancer then end-stage cancer), and © lives long enough to claim the 100-month monthly income. The 150% / 200% / 300% potentials are scenario maxima, not expected values. Most claimants will trigger one or two tiers, not all five.

---

Sweet Spot — Lead with Vital Care (if pitching FOR AIA) or Counter-Position (if pitching AGAINST)

• Age 30–50, family stage, household earner with 1–3 dependents
• Already an existing AIA unit-linked policyholder (Vital Care attaches as a rider — no standalone purchase)
• Household income Rp 15M+/month with sufficient Nilai Akun build-up to absorb the rising CoI without depleting the base investment
• Family history of cancer or cardiovascular disease — multi-stage structure compounds value
• Comfortable with unit-linked architecture; not seeking guaranteed cash-value certainty
• Prefers comprehensive coverage breadth (169 conditions) over premium-cost minimisation

Borderline Fit — Discuss but qualify carefully

• Age 51–65 — CoI scales sharply with age; ensure base policy Nilai Akun is large enough to sustain rider charges for the remaining term. Stress-test with the unit-linked illustration.
• Customers who already have a critical-illness standalone (e.g., Allianz Critical+ or PRUCritical Amanah) — Vital Care duplicates coverage; only worth adding if the existing SA is too low and topping up the existing product is more expensive.
• Customers between base policy renewals — Vital Care can only be attached at issue or per AIA’s add-on windows; check the base contract’s rider-attachment rules.
• Customers who can only afford the Essential plan — they get the 88-condition list and 150% max payout but lose the Cancer Renewal Benefit and Monthly Income Benefit, which are the main differentiators.

Do Not Pitch

• Customers without an AIA unit-linked base policy AND no intention to buy one — Vital Care cannot be sold standalone, and forcing a base policy purchase just to attach a CI rider is a textbook mis-selling pattern under POJK conduct rules.
• Customers seeking a fixed-premium product — the CoI deduction model means the “premium” actually rises with age and is opaque to most retail customers.
• Customers without basic medical/hospitalisation cover — sell BPJS-supplement or an indemnity health plan first; CI lump-sums do not pay hospital bills directly.
• Customers with very low Nilai Akun trajectories where the rider will deplete the base policy within 10–15 years — model the unit-linked illustration before pitching.
• Customers who want CI cover only for cancer — the Optima Cancer Protection rider is cheaper and more targeted.

---

This framework is written from a Legacy Income agent perspective. Vital Care is a competitor product — we sell against it, not for it. The decision logic below tells you when a customer who is being pitched Vital Care is genuinely well-served, and when an Allianz or Tokio Marine alternative is a stronger play.

Rule of thumb for Legacy Income agents: if you hear “saya sudah punya polis AIA” in the discovery conversation, the customer is leaning toward attaching Vital Care and your counter must hinge on (a) the CoI deduction eroding the base policy’s Nilai Akun and (b) the gap between Essential and Ultimate — most customers default to Essential to save cost and end up with a hollow product. If the customer has no AIA exposure, Vital Care is structurally off the table and the conversation pivots to standalone CI alternatives.

---

Category data: 26 catalogued critical-illness products, 23 with extracted PDFs (88.5% coverage), but quantitative metrics fall below the 60% threshold across the board (ci_conditions_count 39.1%, sum_assured_min 26.1%, policy_term 17.4%, premium 17.4%). The category is structurally heterogeneous — comprehensive CI lump-sum products, early-stage CI add-ons, gender/condition-specific products, and recurring-payment CI all coexist. Benchmarking below is qualitative against this backdrop.

Confidence note: structural-dimension claims are drawn directly from the 2026-04-29 brochure; peer-comparison claims are analyst assessment from category knowledge and the master-log of catalogued critical-illness products, not against directly parsed peer RIPLAYs. Refresh trigger: re-run when the RIPLAY for Vital Care becomes available and when at least three peer RIPLAYs (Allianz Critical+, PRUCritical Amanah, Tokio CI Guard) are fully extracted.

---

Note: these are written for Legacy Income agents positioning against Vital Care, not for AIA agents selling it. Where the customer has already started down the AIA path, the talking points are designed to surface what Vital Care does not say.

Opening — reframe the conversation

“Before we talk about which critical-illness product to pick, I want to ask one question: do you already have a unit-linked policy with AIA? Because the product they’re showing you is a rider, not a standalone — and that detail changes the whole comparison.”

“Sebelum kita bicara produk penyakit kritis mana yang dipilih, saya ingin tanya satu hal: apakah Anda sudah punya polis unit-linked di AIA? Karena produk yang mereka tunjukkan ke Anda itu rider, bukan polis berdiri sendiri — dan detail ini mengubah seluruh perbandingannya.”

The structural counter-pitch (CoI drag narrative)

“On paper, Vital Care can pay up to 3x the sum insured. In practice, that only happens if you buy the Ultimate plan and the disease unfolds in a specific sequence. What the brochure does not show you is that the rider’s cost is taken from your base policy’s investment value every month — and that cost rises every year as you get older. Over 20 years, the rider can quietly eat into your investment account. A standalone critical-illness product with a fixed premium gives you the same protection without that drag.”

“Di atas kertas, Vital Care bisa bayar hingga 3 kali Uang Pertanggungan. Pada kenyataannya, itu hanya terjadi kalau Anda ambil plan Ultimate dan urutan penyakitnya sesuai skenario. Yang brosur tidak tunjukkan ke Anda adalah biaya rider-nya dipotong dari Nilai Akun polis dasar setiap bulan — dan biaya itu naik setiap tahun seiring usia. Dalam 20 tahun, rider ini bisa diam-diam menggerus tabungan investasi Anda. Produk penyakit kritis standalone dengan premi tetap memberi proteksi setara tanpa beban itu.”

The Essential-vs-Ultimate gap (positioning trap)

“There are three plan tiers — Essential, Enhance, and Ultimate. The features that make Vital Care interesting — the Cancer Renewal Benefit and the Monthly Income Benefit — are only in Enhance and Ultimate. Many customers downgrade to Essential to save cost and end up with a product whose main selling points have been stripped out. If you can only afford Essential, the better choice is a focused standalone CI product at a lower price.”

“Ada tiga tier plan — Essential, Enhance, dan Ultimate. Fitur yang membuat Vital Care menarik — Manfaat Pembaruan Kanker dan Santunan Penghasilan Bulanan — hanya ada di Enhance dan Ultimate. Banyak nasabah turun ke Essential demi hemat biaya dan akhirnya pegang produk yang fitur utamanya sudah dipreteli. Kalau hanya mampu Essential, pilihan yang lebih baik adalah CI standalone yang lebih fokus dengan harga lebih murah.”

The transparency close

“Ask your AIA agent to show you two things in writing before you sign: first, the cost of insurance schedule by age — so you can see what the rider will cost when you are 50, 60, and 70. Second, the projection of your Nilai Akun with the rider attached versus without. If they cannot show both clearly, you do not have the information you need to make this decision.”

“Minta agen AIA tunjukkan dua hal secara tertulis sebelum Anda tanda tangan: pertama, tabel Biaya Asuransi per umur — supaya Anda lihat berapa biaya rider saat Anda usia 50, 60, dan 70. Kedua, proyeksi Nilai Akun dengan rider terpasang dibandingkan tanpa rider. Kalau mereka tidak bisa tunjukkan keduanya dengan jelas, Anda belum punya informasi yang cukup untuk memutuskan.”

—

These are objections an existing or prospective AIA customer might raise when a Legacy Income agent is positioning an Allianz or Tokio Marine alternative against Vital Care.

1. “AIA covers 169 critical illnesses — that is more than your product.”

Customer “AIA cover 169 penyakit kritis — lebih banyak dari produk Anda.”

Don't say “Numbers don’t matter.” — dismissive and the customer hears it as an excuse.

Don't say “Angka tidak penting.”

Do say “169 is a real number — let’s look at what it means in practice. The top 30 critical illnesses account for over 95% of actual claims in Indonesia. Beyond that, you are paying for low-probability conditions you may never claim. The real question is not how many conditions are listed; it is whether the most common ones — cancer, heart attack, stroke, kidney failure — are covered at adequate sum-assured levels. Our product covers all of those at the level you need, with a fixed premium that does not rise with age.”

Do say “169 itu angka yang sah — mari lihat artinya dalam praktik. 30 penyakit kritis teratas mencakup lebih dari 95% klaim aktual di Indonesia. Di luar itu, Anda bayar untuk kondisi-kondisi yang probabilitas klaimnya sangat rendah. Pertanyaan sebenarnya bukan berapa banyak kondisi yang terdaftar, tapi apakah yang paling sering — kanker, serangan jantung, stroke, gagal ginjal — di-cover dengan Uang Pertanggungan yang memadai. Produk kami cover semua itu di level yang Anda butuhkan, dengan premi tetap yang tidak naik mengikuti umur.”

—

2. “Vital Care can pay up to 3x the SA — that sounds better than your product.”

Customer “Vital Care bisa bayar sampai 3 kali UP — kelihatannya lebih bagus dari produk Anda.”

Don't say “That’s not true.” — it is technically true, just misleading.

Don't say “Itu tidak benar.”

Do say “The 3x number is the theoretical maximum if you have the Ultimate plan and the disease unfolds in a specific sequence — early-stage cancer, then a second early-stage cancer 12 months later, then a different end-stage disease, plus 100 months of monthly income. Most claimants will trigger one or two stages, not all five. The realistic expected payout is closer to 1x to 1.5x SA, the same as a well-structured standalone CI. The headline 3x is marketing, not expected value. Ask your agent to show you the actuarial expected payout, not the theoretical maximum.”

Do say “Angka 3 kali itu maksimum teoritis kalau Anda pegang plan Ultimate dan urutan penyakitnya sesuai skenario — kanker tahap awal, lalu kanker tahap awal kedua 12 bulan kemudian, lalu penyakit tahap akhir yang berbeda, ditambah 100 bulan santunan bulanan. Mayoritas klaim hanya menyentuh satu atau dua tahap, bukan kelima-limanya. Payout realistis ada di kisaran 1 hingga 1,5 kali UP, sama seperti CI standalone yang terstruktur baik. Angka 3 kali itu pemasaran, bukan ekspektasi aktuaria. Minta agen Anda tunjukkan expected payout aktuaria, bukan maksimum teoritis.”

—

3. “BPJS already covers critical illness — why do I need this?”

Customer “BPJS sudah cover penyakit kritis — kenapa saya butuh ini?”

Don't say “BPJS is bad.” — politically loaded and many customers rely on BPJS.

Don't say “BPJS jelek.”

Do say “BPJS pays the hospital for treatment within the BPJS network and procedure list. It does not give you cash. When someone is diagnosed with cancer, the family needs cash for things BPJS does not cover — second-opinion consultations, targeted therapy outside the BPJS formulary, time off work, the cost of bringing a sick parent home from another city, the income gap during recovery. A critical-illness lump-sum gives you that cash, on top of whatever BPJS pays. They are layers, not substitutes. And under the new POJK 36/2025 health rules, any health-insurance overlap requires explicit co-payment disclosure — a CI lump-sum product is structurally cleaner than a health-indemnity overlap with BPJS.”

Do say “BPJS bayar rumah sakit untuk treatment di jaringan dan daftar prosedur BPJS. BPJS tidak kasih Anda cash. Saat seseorang didiagnosa kanker, keluarga butuh cash untuk hal-hal yang tidak di-cover BPJS — konsultasi second opinion, terapi target di luar formularium BPJS, cuti kerja, biaya membawa orang tua sakit pulang dari luar kota, gap penghasilan selama pemulihan. Critical-illness lump-sum kasih Anda cash itu, di atas apapun yang dibayar BPJS. Mereka layer, bukan pengganti. Dan di bawah POJK 36/2025 yang baru, overlap asuransi kesehatan butuh disclosure co-payment yang eksplisit — produk CI lump-sum secara struktural lebih bersih dibanding overlap health-indemnity dengan BPJS.”

—

4. “What about pre-existing conditions and the waiting period?”

Customer “Bagaimana dengan kondisi yang sudah ada sebelumnya dan masa tunggu?”

Don't say “Don’t worry about it.” — this is precisely what creates a future repudiation.

Don't say “Jangan khawatir.”

Do say “This is an important question and you should ask it of every CI product, not just ours. Vital Care excludes pre-existing conditions and any CI whose first diagnosis or first symptom appeared during the waiting period — that is standard across the industry, but the exact waiting-period length is in the policy document, not the brochure. The right thing to do is declare every condition you have on the application, ask the agent to put any open questions in writing, and get the insurer to confirm coverage scope before you sign. If a condition is undisclosed and surfaces later, the claim will be repudiated and you will have paid premiums for nothing. Our product applies the same logic — full disclosure is your protection, not just a formality.”

Do say “Ini pertanyaan penting dan Anda harus tanyakan ini ke setiap produk CI, bukan hanya produk kami. Vital Care mengecualikan kondisi yang sudah ada sebelumnya dan setiap penyakit kritis yang diagnosis pertama atau gejala pertamanya muncul dalam masa tunggu — itu standar industri, tapi durasi masa tunggu yang persis ada di dokumen polis, bukan di brosur. Yang benar adalah deklarasikan setiap kondisi yang Anda miliki di formulir aplikasi, minta agen tulis pertanyaan terbuka secara tertulis, dan minta insurer konfirmasi cakupan sebelum tanda tangan. Kalau ada kondisi tidak dideklarasi dan muncul kemudian, klaim akan ditolak dan Anda sudah bayar premi sia-sia. Produk kami pakai logika yang sama — full disclosure itu proteksi Anda, bukan sekadar formalitas.”

—

5. “I’m 55 — am I too old for this?”

Customer “Saya 55 — apakah saya terlalu tua untuk ini?”

Don't say “Yes.” — closes the conversation prematurely.

Don't say “Ya.”

Do say “Vital Care accepts entry up to age 70, so technically you qualify. The harder question is economics. At age 55, the cost-of-insurance for a CI rider rises steeply each year — and because Vital Care debits that cost from the unit-linked Nilai Akun, the rider will burn through your investment account faster than at a younger entry age. For your stage, a focused standalone CI with a level premium is often the more durable structure. We can run both numbers — Vital Care attached to an AIA base policy versus a standalone CI — and you can see the 20-year cost side by side before deciding.”

Do say “Vital Care menerima entry sampai umur 70, jadi secara teknis Anda memenuhi syarat. Pertanyaan yang lebih sulit adalah ekonominya. Di umur 55, biaya asuransi untuk CI rider naik tajam setiap tahun — dan karena Vital Care memotong biaya itu dari Nilai Akun unit-linked, rider akan membakar tabungan investasi Anda lebih cepat dibanding kalau entry di umur lebih muda. Untuk tahap hidup Anda, CI standalone yang fokus dengan premi level seringkali struktur yang lebih tahan lama. Kita bisa hitung dua-duanya — Vital Care yang nempel di base AIA versus CI standalone — dan Anda bisa lihat biaya 20 tahun bersebelahan sebelum memutuskan.”

—

These are the issues most likely to trigger an OJK complaint or a 2026-rule violation when an agent (AIA or otherwise) pitches against or alongside Vital Care.

1. Document availability gap. This brief is written from the 2026-04-29 brochure only. The RIPLAY for Vital Care has not been extracted into the Market Intelligence repository at the time of writing. No agent in Legacy Income should make binding claims about Vital Care exclusions, waiting periods, or claim mechanics without first cross-referencing the actual policy wording. All counter-positioning language in this brief is structural, not contractual.

2. 3x SA headline overpromise. Quoting “up to 3x Sum Assured” without the conditional structure (Ultimate plan, specific disease sequence, 100-month survival) is mis-selling. If a Legacy Income agent is positioning against Vital Care, do not mock the 3x headline; instead surface the expected-value math and let the customer draw the conclusion.

3. Mixing the rider with the base policy. Vital Care is a rider on a unit-linked base policy. A customer who confuses the two — believing Vital Care is a standalone CI with its own premium — does not understand the product. If you encounter this confusion, document it on the consultation note and clarify before any application is signed.

4. CoI-deduction transparency. The Cost of Insurance scales by age, gender, smoker status, SA, and plan, and is debited from the base policy’s Nilai Akun. Customers should see a 20-year CoI projection with and without the rider before signing. If an agent has not shown that projection, the sale is at risk of a future complaint when the base policy’s investment value disappoints.

5. POJK 36/2025 co-payment overlap with health products. Vital Care is a CI lump-sum product, not a health indemnity, so the 10% co-payment rule does not directly apply. However, if Vital Care is bundled in a single illustration with an AIA health-indemnity product (e.g., HSCP or HealthShield), the co-payment disclosure must accompany the health portion. Agents pitching against Vital Care should not conflate the rules — keep the CI conversation distinct from the health conversation.

6. Pre-existing condition and waiting-period disclosure. Vital Care excludes pre-existing conditions and CIs whose first diagnosis or first symptom emerged during the waiting period. Any application submitted with material non-disclosure exposes the customer to claim repudiation. Always escalate ambiguous health-history items to underwriting before signing.

7. Essential-plan downgrade trap. Customers who default to Essential to save cost lose the Cancer Renewal Benefit and Monthly Income Benefit — the two features that justify Vital Care’s premium positioning. Any agent recommending Essential should document on the consultation note why Enhance/Ultimate was declined; otherwise a future complaint that “the agent did not explain the difference” is hard to defend.

---

---

1. Build a “CoI drag” calculator in Bahasa Indonesia — a one-page spreadsheet that lets an agent input customer age, gender, smoker status, base policy Nilai Akun, and Vital Care SA, and projects the 20-year erosion of the Nilai Akun from the rider’s CoI debits versus a like-for-like standalone CI premium. This is the highest-leverage tool for the counter-pitch and the single most persuasive artifact in any AIA-customer discovery conversation.

2. Trigger RIPLAY extraction for Vital Care. This brief was written brochure-only because the RIPLAY is missing from the repository. The Indonesia Life Insurance market intelligence has a known PDF-extraction backlog (proposal at Insurance-Agency\Market-Intelligence\Indonesia-Life-Insurance\proposals\2026-04-28-pdf-extraction-sweep-proposal.md); push Vital Care to the priority queue. Until the RIPLAY is in the repository, all counter-positioning language is structural, not contractual.

3. Train agents on the Essential-vs-Ultimate trap. Most AIA-customer prospects will have been pitched Essential because it is the cheapest tier. The talking-point library should walk agents through how to surface that Essential strips out the Cancer Renewal Benefit and Monthly Income Benefit — the two features that make Vital Care’s price tag defensible. Build a one-page comparison card for field use.

4. Pair-sell mindset: when a Legacy Income agent encounters a prospect who has an AIA unit-linked base policy, the first question is not “should we replace the AIA policy?” — replacement is rarely in the customer’s interest given surrender penalties. The question is “what is the gap?” A focused CI top-up via Allianz Critical+ or Tokio CI Guard can complement, not replace, an existing AIA base policy and avoids triggering twisting/replacement scrutiny under OJK conduct rules.

5. Refresh trigger. Re-run this brief when (a) the Vital Care RIPLAY is extracted, (b) at least three peer CI products (Allianz Critical+, PRUCritical Amanah, Tokio CI Guard) have been fully RIPLAY-parsed, and © the critical-illness category quantitative coverage exceeds 60% on ci_conditions_count and policy_term_years. Until then, treat this brief as a structural and qualitative reference, not a basis for binding claims about Vital Care.

---